A part of Watch Media

Sunday2 April 2023

15/07/2022at 15:25

Top news from MedWatch this week

Miss anything?

Photo: MedWatch

by MIKKEL AABENHUS HEMMINGSEN

Monday

Novo CEO spies new pricing model in EU

Novo Nordisk to test diabetes tablet against Eli Lilly drug

Tuesday

Leo Pharma pulls the plug on Leo Innovation Lab

Novo Nordisk’s hemophilia drug shows potential as once-monthly treatment

Father hands over Pharmacosmos reins to son

Wednesday

European Dermatology Forum recommends Leo Pharma drug in line with other biologics

Think tank predicts life science sector role to grow as EU struggles to stay innovative

Analyst forecasts potential Novo Nordisk upgrade in strong second quarter outlook

Thursday

Novo Nordisk’s Wegovy earns B+ from US nonprofit research organization

Y-mabs enters clinic with new cancer candidate

Infosys inks EUR 110m deal to acquire Base life science

Friday

Pharmacosmos leadership passed down to third generation: ”It’s been in the cards”

Rhovac CEO quits after failed study

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Front page now

Per Wold-Olsen officially stepped down as GN's chair at the company's AGM | Foto: Mik Eskestad

Former GN chair says there have been no acquisition signs from Demant owner

Per Wold-Olsen left the chairperson position two weeks ago after 15 years – he now reveals there haven’t been acquisition talks behind closed doors during his time at the company.

For subscribers

Foto: Rob Acket/ema

CHMP recommends nine drugs in March

For subscribers

Nicolai Buhl, executive vice president for innovation at Coloplast, is busy winning a clinical contest against a catheter competitor | Foto: Mik Eskestad

Coloplast challenges its biggest catheter competitor in clinical contest

For subscribers

Foto: MedWatch

Top news from MedWatch this week

Foto: Bavarian Nordic / Pr

Pharma & biotech

Former Bavarian Nordic chairman sees opportunities in Johnson & Johnson's RSV exit

For subscribers

Foto: George Frey

Pharma & biotech

Novo Nordisk helps Canada resolve Ozempic issue

For subscribers

Further reading

Minister for the Interior and Health of Denmark Sophie Løhde must answer questions concerning Novo Nordisk's funding of a Danish patient group | Foto: Ida Marie Odgaard

Pharma & biotech

Danish health minister to answer questions about Novo Nordisk sponsorship of patient group

The Danish minister for health has six business days to answer questions posed by a parliamentarian.

For subscribers

Foto: George Frey

Pharma & biotech

Novo Nordisk helps Canada resolve Ozempic issue

Americans were reportedly crossing the border seeking the diabetes drug with a strong weight-loss effect until barred from purchases.

For subscribers

Per Wold-Olsen officially stepped down as GN's chair at the company's AGM | Foto: Mik Eskestad

Former GN chair says there have been no acquisition signs from Demant owner

Per Wold-Olsen left the chairperson position two weeks ago after 15 years – he now reveals there haven’t been acquisition talks behind closed doors during his time at the company.

For subscribers

Jobs